|
MED19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.752080E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.322300E-02 |
| Normal-vs-Stage2 |
2.106000E-01 |
| Normal-vs-Stage3 |
4.570100E-04 |
| Normal-vs-Stage4 |
6.009000E-01 |
| Stage1-vs-Stage2 |
8.533600E-01 |
| Stage1-vs-Stage3 |
2.259800E-02 |
| Stage1-vs-Stage4 |
1.626220E-01 |
| Stage2-vs-Stage3 |
1.547980E-01 |
| Stage2-vs-Stage4 |
4.302600E-01 |
| Stage3-vs-Stage4 |
4.581600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.748410E-02 |
| Normal-vs-AfricanAmerican |
3.779800E-02 |
| Normal-vs-Asian |
8.056800E-01 |
| Caucasian-vs-AfricanAmerican |
8.118200E-01 |
| Caucasian-vs-Asian |
5.019000E-01 |
| AfricanAmerican-vs-Asian |
4.784400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.921900E-02 |
| Normal-vs-Female |
3.742500E-03 |
| Male-vs-Female |
3.946600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.026000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.625700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.440200E-03 |
| Normal-vs-Age(81-100Yrs) |
8.958200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.150600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.776800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.782000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.273200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.009200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.204000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.531000E-01 |
| Normal-vs-Grade 2 |
3.781700E-02 |
| Normal-vs-Grade 3 |
1.257300E-03 |
| Normal-vs-Grade 4 |
6.424200E-01 |
| Grade 1-vs-Grade 2 |
9.039200E-01 |
| Grade 1-vs-Grade 3 |
6.699000E-01 |
| Grade 1-vs-Grade 4 |
5.122000E-01 |
| Grade 2-vs-Grade 3 |
1.263240E-01 |
| Grade 2-vs-Grade 4 |
2.177600E-01 |
| Grade 3-vs-Grade 4 |
3.376000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.196700E-03 |
| Normal-vs-ccB subtype |
6.820400E-03 |
| ccA subtype-vs-ccB subtype |
5.057600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.276370E-02 |
| Normal-vs-N1 |
7.880400E-01 |
| N0-vs-N1 |
5.373400E-01 |
|
|
